XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 35,139,109 $ 1,609,694
Short-term investments 50,000 50,000
Accounts receivable 32,453 4,157
Prepaid research and development contracts 297,158 353,434
Other current assets 602,488 209,038
Total current assets 36,121,208 2,226,323
Furniture and equipment, net 138,147 149,595
Deposits 20,960 20,960
Total assets 36,280,315 2,396,878
Current liabilities:    
Accounts payable and accrued expenses 2,970,048 2,470,970
Convertible notes   12,386,647
Total current liabilities 2,970,048 14,857,617
Commitments and contingencies (Note 10)
Redeemable convertible preferred stock (all classes)   73,757,890
Stockholders’ equity (deficit):    
Common stock, $0.0001 par value per share; 300,000,000 and 17,440,436 shares authorized and 27,049,555 and 1,240,925 shares issued and outstanding at March 31, 2017 and December 31, 2016 respectively. 2,705 124
Additional paid-in capital 125,465,315  
Accumulated deficit (92,157,753) (86,218,753)
Total stockholders’ equity (deficit) 33,310,267 (86,218,629)
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit) $ 36,280,315 $ 2,396,878